RecruitingHeart DiseaseVascular DiseaseHeart Failure
Studies of Neuregulin/ERBB Signaling in Human Heart
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study examines the role of the epidermal growth factor (EGF) receptor family and the EGF family of ligands in the regulation of non-myocytes isolated from the human heart.
Sponsor: Douglas B. Sawyer
You may qualify if…
- ✓ Clinical diagnosis of severe coronary artery disease scheduled to undergo coronary artery bypass surgery.
You may not qualify if…
- ✕ less than 18 years of age
- ✕ unwilling or unable to provide informed consent
- ✕ known active myocarditis
- ✕ hypertrophic cardiomyopathy
- ✕ constrictive pericarditis or other significant pericardial disease
- ✕ severe pulmonary hypertension
- ✕ significant renal impairment (Cr \> 2.5 mg/dL)
- ✕ severe ventricular arrhythmias
Where it's recruiting
Maine
Portland
Source: ClinicalTrials.gov · NCT02820233 · last updated 2025-04-03